Highlights 26 1. The IPP-bypass pathway was optimized to substantially improve isoprenol titer. 27 2. PMD mutant was introduced for MVAP conversion with high efficiency. 28 3. Isoprenol titer reached 3.7 g/L in batch cultures at 44% of the theoretical yield. 29 4. The highest isoprenol titer (10.8 g/L) was achieved in fed-batch fermentations. 30 5. Use of a solvent overlay improved titer by removing the toxic final product. Abstract 32
Introduction

51
Increasing concerns about the cost and environmental impact of petroleum-derived fuels 52 (Baral et al., 2019) has motivated the development of microbial hosts for the production 200 g/L glucose, 15 g/L MgSO4 . 7H2O, 5 g/L yeast extract (if needed), micronutrients 142 according to previous descriptions (Korz et al., 1995) and appropriate antibiotics; also, 143 antifoam B was added to the bioreactor when required. Glucose feeding was carried out 144 using a Watson-Marlow DU520 peristaltic pump; for constant feeding, the flow rate was 145 selected to closely match the glucose consumption rate at the end of the batch phase. For 146 exponential feeding, the feeding rate was changed every hour (for a total of 12 hours) and 147 calculated according to the following equation (Korz et al., 1995) :
where m(t) is the mass flow of the substrate (g/h), µ is the specific growth rate (0.1 h -1 ), 150 YX/S is the biomass/substrate yield coefficient (0.5 g/g), m is the specific maintained 151 coefficient (0.025 g g -1 h -1 ), VtF is the cultivation volume at the time of feeding (tF) and 152 XtF is the biomass concentration (g/L). After 12 hours of exponential feeding, the feeding 153 rate was set constant and glucose was continuously measured in the medium, and the 154 feeding rate was adjusted to prevent its accumulation at more than 2 g/L. For the two-155 phase cultivation, 20% (v/v) oleyl alcohol was added to the fermenter at the time of 156 induction. During the fed-batch phase, additional oleyl alcohol was added so its volume 157 never decreased below 10% of the total volume. For OD600nm measurement and isoprenol 158 quantification during the two-phase cultivation, the sample was first separated by 159 centrifugation (8 min, 4000 x g) and the aqueous phase was used to quantify isoprenol as 160 described above (except that up to 1:3 dilutions with ethyl acetate were used for isoprenol 161 concentrations greater than 2 g/L) as well as OD600nm and DCW (dry cell weight) 162 measurements; in order to quantify isoprenol from the organic phase, 10 µL of the oleyl 163 alcohol was added to 990 µL ethyl acetate containing 1-butanol as an internal standard 164 and the total isoprenol was calculated based on the actual culture volume at the time of 165 the sampling. For analysis of metabolites from the IPP-bypass pathway, 0.5-1 mL of cell culture was 181 centrifuged at 14,000 x g for 3 min at 4°C, the cell pellets were resuspended in 250 µL of 182 methanol and stored at 20°C. Pellets were thawed on ice and combined with 250 μL 183 water, the methanol-water mixtures were centrifuged at 15,000 rpm for 10 min at 4°C shown in Figure 1B ); isoprenol production reached 513 mg/L after 48 hours using EZ-
207
Rich medium supplemented with 1% glucose (strain AK01, Figure 2A ). Using this strain 208
as a baseline, we tested different expression levels of MK, HMGR, and HMGS in order 209 to identify limiting steps for the biosynthesis of MVAP in the IPP-bypass pathway.
210
First, we tested whether increasing the expression of the MK would affect isoprenol 211 production. We expressed MK (i.e., MK_Sc_co) from a high-copy plasmid (ColE1-212 origin) with a Trc promoter instead of the medium-copy plasmid (p15A origin, Figure   213 1C), which increased the isoprenol titer significantly, reaching 1.05 g/L (strain AK02, 214 Figure 2A ), suggesting that isoprenol production might be limited by MVAP levels. To 215 test whether the changes in expression of the enzymes upstream of the MK such as 216 HMGS and HMGR would also improve isoprenol production, we tested variants of these 217 enzymes from different organisms ( Table 1) . HMGRs with higher forward reaction activity were overexpressed, which suggests that 236 production of isoprenol could be limited by the availability of mevalonate and 237 mevalonate phosphate (MVAP). Several MK variants were also tested but titers were not 238 improved ( Figure 2C ). We also tested if higher HMGR expression would positively 239 affect carbon flux towards mevalonate as HMGR is known as a rate-limiting enzyme of 240 the top pathway (acetyl-Co to mevalonate), but expression of an additional copy of the 241 HMGR from a high-copy plasmid did not improve titers either ( Figure 1D ); in fact, a 242 decrease in isoprenol production was observed compared to the control strain regardless 243 of the HMGR variant used ( Figure 2D ). Further analysis of one of these HMGR-244 overexpressing strains (strain AK19) showed that expression of this additional enzyme 245 from the high-copy plasmid resulted in a lag phase after induction (Supplementary Figure   246 1A), which indicates that growth of the strain was inhibited; the growth recovered after 247 40 hours but this increase in cell biomass did not result in an increase of isoprenol 248 production (Supplementary Figure 1B) . Quantification of intermediate metabolites 249 showed an increase in MVAP levels when the additional HMGR was expressed but no 250 accumulation of other potentially toxic intermediates was observed (Supplementary 251 Figure 1C ). We also tested whether overexpression of the HMGR itself was toxic to the 252 cells, but overexpression of only the HMGR_Sc_co from a pTrc promoter from a high-253 copy number plasmid did not inhibit growth (data not shown). Based on the results from the previous section, we hypothesized that the conversion of 257 MVAP to IP might also be a bottleneck in the pathway. Therefore, in order to improve 258 the conversion of MVAP to IP, we tested a PMD mutant (R74G) that was reported to 259 have higher Ki than the wild-type PMD (MVAP is a non-competitive inhibitor of PMD) 260 (Kang et al., 2017) . Initially, both the wild-type PMD (strain AK07) and the R74G 261 mutant (strain AK21) were expressed with enzyme variants described in the previous 262 section containing the HMGS_Sc_co, HMGR_Sc_co, and MK_Sc_co. The maximum 263 isoprenol titers of two strains were similar, but there was a significant improvement in 264 rate of production with the R74G mutant (strain AK21) compared to the wild-type PMD 265 (strain AK07), reaching a maximum titer of 1.6 g/L after 30 hours instead of 40 hours 266 ( Figure 3A) . The strain AK21 also showed faster growth ( Figure 3B ) and faster glucose 267 consumption ( Supplementary Figure 2A ). Acetate accumulation peaked at 6 hours after MVAP were significantly lower in the strain with the R74G mutant (strain AK21) 275 compared to those of the strain with the wild-type PMD (strain AK07), whereas the IP 276 levels were higher, suggesting that using the R74G mutant increases the conversion of 277 MVAP to IP. The strain AK21 also showed lower mevalonate concentrations, suggesting 278 that mevalonate was converted to MVAP more efficiently in strain AK21 than in strain 279 15 AK07, where mevalonate increased over time and reached a final concentration four 280 times higher than in strain AK21 after 24 hours ( Figure 3B ).
281
In addition to the R74G mutant, two other PMD mutants with higher kcat or higher Ki for 282 MVAP were identified in our previous study, and these mutants could increase the 283 conversion efficiency of MVAP to IP and improve isoprenol production (Kang et al., 284 2017); one contains a single R74H mutation and the other contains three mutations,
285
R74H, R147K and M212Q (abbreviated as HKQ). The PMD with these mutations were 286 also tested with the HMGS_Sc_co-HMGR_Sc_co-MK_Sc_co system (strains AK22 and 287 AK23, respectively) but lower isoprenol titers were observed ( Figure 4A ). We 288 hypothesized that other HMGS, HMGR, and MK variants could provide different 289 metabolite levels for the upstream intermediates, which could have synergistic effects on 290 isoprenol production for the PMD mutants. Therefore, two additional strains containing 291 the HMGS_Sa-HMGR_Sa-MK_mm or the HMGS_Sa-HMGR_Sa-MK_Sc_co (which 292 showed high isoprenol titers in the previous section) were also tested with the PMD 293 mutants ( Figure 4A ). Interestingly, very different isoprenol titers were observed for each 294 PMD mutant depending on the HMGS-HMGS-MK system used; these differences were 295 more significant with the R74H mutant, where the titer ranged from 784 mg/L for strain 296 AK22 to 1.84 g/L for strain AK28 ( Figure 4A ). In general, higher titers were observed 297 using the HMGS_Sa-HMGR_Sa-MK_Sc_co system, reaching a maximum titer of 1.84 298 g/L with the R74H mutant (strain AK28) and 1.81 g/L with the HKQ mutant (strain 299 AK29). Because of its greater batch-to-batch consistency and lower cost, chemically defined 303 minimal medium is usually employed for production in bench-scale fermentations;
304 however, since all metabolites need to be synthesized de novo, growth in minimal 305 medium can result in major shifts in cell resources and affect production (Singh et al., 306 2017). Therefore, we tested our previously optimized strains for production on minimal 307 medium supplemented with 1% glucose; isoprenol production was approximately half of 308 that obtained with rich medium (Supplementary Figure S3 ). Increasing the glucose 309 concentration to 2% generally resulted in higher titers, except for a few strains (e.g.,
310
AK28 and AK29), but the degree of improvement varied depending on the MK, HMGS,
311
HMGR, and PMD variants used ( Figure 4B ). In general, strains with lower isoprenol 312 production showed slower growth and higher acetate accumulation (data not shown). The 313 highest isoprenol titer was achieved when the R74G PMD mutant was expressed with the 314 HMGS_Sc_co-HMGR_Sc_co-MK_Sc_co system (strain AK21), reaching titers of 2.74 315 g/L. Comparable titers were also observed with strains AK27, AK25 and AK26.
316
Interestingly, more than a 10-fold difference in isoprenol titer was observed for the R74G 317 mutant depending on the HMGS-HMGR-MK system used (ranging from 246 mg/L for 318 strain AK24 to 2.74 g/L for strain AK21; Figure 4B ). The initial glucose concentration 319 affected not only the titer but also the yield; for example, for strain AK26, the yield from 320 1% glucose was 0.095 g isoprenol per g glucose, whereas from 2% glucose the yield was 321 0.14 g isoprenol per g glucose; the latter is close to 44% of the theoretical yield using the 322 MVA pathway (Dugar and Stephanopoulos, 2011) . In both cases, the stationary phase 323 was reached after 20 hours ( Figure 5A ), therefore, it is possible that the higher yield with 324 2% glucose was due to additional isoprenol produced during stationary phase when 325 production could occur without cell growth. The glucose consumption rates of AK26 in 326 minimal medium supplemented with 2% glucose were slower (0.37 g glucose per hour) 327 than those in the medium with 1% glucose (0.49 g glucose per hour; Figure 5B ), but there 328 was no significant difference in the isoprenol production rate or biomass production 329 estimated by OD600nm while glucose was being consumed ( Figure 5C ). Although both the 330 glucose consumption and isoprenol accumulation increased linearly until the glucose was 331 fully consumed, it is interesting to note that no increase in growth (OD600nm) S4). Three of the strains with the highest titers (AK21, AK26 and AK27) were further 339 tested for production using minimal medium supplemented with 3% glucose ( Figure 6 ).
340
Interestingly, a significant improvement in titer was observed for strain AK26, reaching 341 3.71 g/L of isoprenol after 63 hours ( Figure 6A ), but not for strains AK27 and AK21. A 342 higher glucose consumption rate and less acetate accumulation were observed for strain 343 AK26, which might explain the difference in titers ( Figure 6B and 6C) . The yield for 344 strain AK26 using 3% glucose was the same as when 2% glucose was used (0.14 g 345 isoprenol per g glucose), whereas ethanol accumulated to 1.9 g/L ( Figure 6D ) and acetate 346 was not produced at significant levels (0.3 g/L, Figure 6B ). To test if higher titers and yields of isoprenol could be achieved in a bioreactor by 359 feeding additional glucose, the optimized strain presented in the previous section (strain Supplementary Table S1 ). Figure 7A shows that production of isoprenol for Ferm 1 368 continuously increased during the fermentation, reaching a titer of 3.55 g/L and a yield of that the OD600nm reached 6.2 at 22 hours and that the glucose in the batch medium was 372 depleted after 48 hours of cultivation (Supplementary Figure S5 ). This result suggests 373 that growth was halted even before all glucose was consumed. Therefore, we hypothesize 374 that nutrients other than glucose might be limiting growth during the batch phase. When
375
we increased the concentration of the nitrogen source (NH4Cl) in the batch medium, from 376 a C/N ratio of 18 in Ferm 1 to a ratio of 10 (Ferm 2), a maximum OD600nm of 7.5 was 377 reached at 22 hours (see Ferm 2 in Figure 7B ). Also, there was a significant reduction in 378 the time needed for the complete consumption of the initial glucose in the batch culture 379 from 55 hours to 30 hours (see Supplementary Figure S5 ), reflecting a higher glucose 380 consumption rate for Ferm 2 compared to that of Ferm 1. Despite the higher biomass 381 accumulation during the batch phase, the maximum isoprenol titer for Ferm 2 was 3.44 382 g/L at 119 hours, which is similar to that of Ferm 1 ( Figure 7A ).
383
Instead of feeding glucose at a constant rate, more efficient feeding strategies have been 384 developed in order to prevent overfeeding or underfeeding of the substrate; in particular, 385 feeding the limiting substrate at an exponentially increasing rate results in constant 386 specific growth rates (Korz et al., 1995) . Therefore, we changed the feeding strategy from 387 constant feeding to exponential feeding (see Materials and Methods for details). As 388 shown in Figure 7B the exponential feeding strategy (Ferm 3) resulted in a continuous 389 increase in OD600nm during the first 50 hours of the fermentation (c.f. batch phase ended 390 ca. 30 hours), a maximum OD600nm of 11.1, and a significant increase in isoprenol titer, 391 reaching a maximum titer of 4.86 g/L.
392
It has been shown that E. coli growth on minimal medium containing ammonium salts as 393 a sole nitrogen source can be significantly improved by supplementing the medium with 394 20 an organic nitrogen source such as yeast extract, as it provides amino acids that can be 395 directly used for enzyme synthesis (Hugo and Lund, 1968) . Therefore, we supplemented 396 the cultivation medium with yeast extract (10 g/L in the batch phase and 5 g/L during the 397 fed-bath phase) to test its effect on growth and production of isoprenol. As can be seen in 398 Figure 7B (Ferm 4) , supplementing the medium with yeast extract resulted in higher OD 399 values compared to previous fermentations, reaching a maximum OD600nm of 16.7.
400
Moreover, the isoprenol titer also improved, reaching a maximum of 5.42 g/L after 94 401 hours. Since exponential feeding and the addition of yeast extract (which constituted less 402 than 10% of the total carbon added) resulted in significant improvements in OD600nm and 403 titer, these conditions were used for further fermentations. During the optimization of the medium and feeding strategy, it was observed that the 407 OD600nm of the culture decreased after 46 hours (see Ferm 4 in Figure 7B ), and a 408 significant amount of acetate (1.5 g/L) was observed at 54 hours; acetate concentration 409 continued to increase to more than 6.6 g/L by the end of the fermentation (see Ferm 4 in 410 Figure 8A ). Acetate accumulation not only represents a loss of carbon but it can also be 411 detrimental to cell growth at concentrations as low as 1 g/L, affecting the stability of respectively (see Figure 1A ). To minimize acetate production during the fermentation, a 417 strain in which these acetate-pathway genes were deleted (strain AK30) was used for 418 isoprenol production in the fermenter. No acetate was detected during the fermentation 419 when this mutant strain was used (Ferm 5, Figure 8A) ; moreover, there was no significant 420 decrease in OD600nm during the cultivation as was previously observed for the wild-type 421 strain (Ferm 4, Figure 7B ).
422
The glucose consumption rate for the mutant strain was similar to that of the wild-type 423 strain ( Figure 8D ) but the isoprenol titer increased 14%, reaching 6.15 g/L after 95 hours 424 ( Figure 8C ). This result suggests that removal of acetate pathway prevented the loss of 425 carbon to acetate, improving the conversion of glucose in Ferm 5. When the glucose 426 concentration in the batch phase was increased from 2% to 3%, the isoprenol titer was 427 further improved, reaching a maximum of 6.84 g/L at 79 hours (yield of 0.084 g/g); no 428 significant accumulation of acetate was detected (see Ferm 6 in Figure 8 ) as was the case 429 for Ferm 5. The maximum OD600nm was greater with 3% glucose in which additional
430
NH4Cl was added to maintain a C/N = 10, reaching a value of 25 at 33 hours. This result 431 suggests that the conversion of glucose into isoprenol was further improved by increasing 432 biomass available during fed-batch phase. Based on these results, we used the strain with 433 the acetate-pathway genes deleted for further optimization of the isoprenol production 434 with 3% initial glucose. As shown in Figure 8B , there was no significant increase in OD600nm resulting in a decline in growth rate and cell viability (Huffer et al., 2011; Ingram, 1986) .
448
In the case of E. coli, it has been reported that isoprenol can be toxic at concentrations as 449 low as 2.4 g/L (Foo et al., 2014) . Two-phase cultivations, in which an organic solvent is 450 used to continuously extract a product in situ, can be used as a strategy to reduce the toxic 451 effects of the product and to increase its yield (Malinowski, 2001) . In particular, oleyl 452 alcohol has been shown to be an effective solvent for the extraction of short-chain 453 alcohols in two-phase cultivations (Connor et al., 2010; Roffler et al., 1987) .
454
Therefore, oleyl alcohol (20% v/v) was added to the bioreactor at the time of induction 455 and the cultivation was carried out as described in the previous section, except that 456 isoprenol was measured both in the aqueous and the organic phases. When the two-phase 457 cultivation with oleyl alcohol (Ferm 7) was used, significantly higher OD values were 458 achieved compared to those of the one-phase cultivation (Ferm 6; Figure 9A) ; moreover, 459 the OD600nm from two-phase cultivation (Ferm 7) increased throughout cultivation and 460 reached a maximum value of 44.6 at 95 hours, which is a substantial improvement in 461 growth compared to Ferm 6. Accumulation of greater biomass during the two-phase 462 cultivation (Ferm 7) was confirmed by DCW measurements (see Supplementary Figure   463 23 S6A). Isoprenol production was also significantly higher when the two-phase cultivation 464 strategy was used ( Figure 9B) , reaching a maximum titer of 10.8 g/L at 95 hr with a yield 465 of 0.105 g/g glucose and a maximum productivity of 0.157 g L -1 hr -1 . Further analysis 466 showed that the amount of isoprenol coming from the aqueous phase accounts for ca. 467 62% (6.7 g/L) of the total isoprenol produced and the amount of isoprenol coming from 468 the oleyl alcohol phase accounts for ca. 38% (4.1 g/L) of the total isoprenol produced 469 (Supplementary Figure S6C) . It is noteworthy that the maximum aqueous-phase 470 concentration of isoprenol for the two-phase cultivation was very similar to the maximum 471 concentration reached in the fermentation without an overlay (see Figure 9B and 472 Supplementary Figure S6D ). This result shows that a continuous product extraction using 473 an overlay can be an effective strategy for producing isoprenol at high titers and reducing 474 its detrimental effect on growth by maintaining a low concentration of the toxic product 475 in the producing culture.
476
Since the use of two-phase fermentations at larger scales could be challenging in terms of 477 the cost and the downstream processing, production of isoprenol at high titers and at 478 larger scales might require the development of strategies to alleviate the toxicity of 479 isoprenol without the use of organic solvents. Improving E. coli's tolerance to isoprenol 480 by expressing efflux pumps or transporters (Foo et al., 2014) or by directed evolution is a 481 promising strategy that could allow production at high titers without the need for two-482 phase fermentation, but further host engineering would be required for this goal. The IPP-bypass pathway was optimized for production of isoprenol in E. coli by 486 improving the biosynthesis of MVAP and its conversion to IP, a direct precursor of 487 isoprenol. A series of metabolic engineering efforts improved the isoprenol production 488 substantially, reaching 3.7 g/L (0.14 g isoprenol per g glucose) in batch fermentations 489 using minimal medium. The use of fed-batch fermentation allowed production of 490 isoprenol at 10.8 g/L, which is the highest reported titer for this compound. In addition to 491 medium optimization and the elimination of acetate accumulation, production at high 492 titers required the use of a two-phase cultivation process whereby isoprenol was partially 493 removed from the aqueous phase into an organic overlay. The removal of isoprenol from 494 the aqueous phase contributed to relieving its toxicity, resulting in considerably higher 495 biomass levels in the cultivation with an organic overlay. was supplemented with 1% glucose and isoprenol production was measured at 48 hr.
646
Minimal medium was supplemented with 2% glucose and isoprenol production was (OD600nm). Fermentations were run at 30°C with 2% glucose in the batch medium using 663 strain AK26. Ferm 1: batch medium with C/N=18 and constant feeding, feed started at 54 664 hours; Ferm 2: batch medium with C/N=10 and constant feeding, feed started at 31 hours;
665
Ferm 3: batch medium with C/N=10 and exponential feeding, feed started at 31 hours;
666
Ferm 4: batch medium with C/N=10, 10 g/L yeast extract and exponential feeding, feed 667 started at 23 hours. Supplementary Table S1 : Titers, yields and maximum productivities for the different strains and fermentation conditions used in this study. Yield calculations correspond to the time at which the maximum titer was reached (grams of isopentenol /grams of glucose consumed). Productivity corresponds to the maximum productivity reached during the fermentation
